Skip to main content
. 2022 May 27;15(5):1347–1364. doi: 10.14202/vetworld.2022.1347-1364

Table 6.

GSH and TAC activities in rat serum with acute aflatoxicosis and after therapy.

Parameters Healthy control (n=8) AFB1 (n=8) AFB1+IV BM-MSCs (n=8) AFB1+IH BM-MSCs (n=8) AFB1+IV HDCs (n=8) AFB1+IH HDCs (n=8) p-value
GSH (nmol/mL) 33.51±2.64 20.18*±3.73 32.86a±2.11 27.55±3.09 23.76±1.65 30.33a±2.17 0.0125
TAC (mM/L) 1.76+0.24 0.48**+0.03 1.54b+0.36 0.76+0.03 0.54+0.08 0.56+0.07 0.0331

In the same row,

*

and

*

are significantly different than control at P<0.05 and P<0.01 respectively and

a

and

b

are significantly different than AFB1 at P<0.05 and P<0.01, respectively. AFB1=Aflatoxin B1, IV=Intravenous, IH=Intrahepatic, BM-MSCs=Bone marrow mesenchymal stem cells, HDCs=Hepatogenic differentiated cells, GSH=Reduced glutathione, TAC=Total antioxidant capacity